rs1085307325
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PS4_ModeratePM1PM5PP3PM2_Supporting
This summary comes from the ClinGen Evidence Repository: BMPR2 c.1259G>A is a missense variant predicted to cause substitution of cysteine to tyrosine at amino acid position 420 (p.Cys420Tyr). The variant is absent from gnomAD v2.1.1 and v4.1 (PM2_supporting). A REVEL score of 0.924 meets PP3_supporting (>0.75). This variant resides within the conserved catalytic kinase domain but does not affect a known critical residue (PM1_moderate). The variant has been reported in four unrelated PAH probands (PMID:15146475, 16429395, 21737554) with additional citations referring back to the same individuals (PMID:21801371, 32634488, 30578397) (PS4_moderate). A different missense variant at the same amino acid residue, p.Cys420Arg (PMID:11115378, 21801371) was previously classified by the PH VCEP as pathogenic (PM5_moderate). In summary, this variant meets the criteria to be classified as a likely pathogenic variant for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PS4_moderate, PM1_moderate, PM5_moderate, PM2_supporting, PP3_supporting (VCEP specification version 1.1, 1/18/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA350341979/MONDO:0015924/125
Frequency
Consequence
NM_001204.7 missense
Scores
Clinical Significance
Conservation
Publications
- pulmonary arterial hypertensionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- pulmonary hypertension, primary, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital heart diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Pulmonary arterial hypertension Pathogenic:1
BMPR2 c.1259G>A is a missense variant predicted to cause substitution of cysteine to tyrosine at amino acid position 420 (p.Cys420Tyr). The variant is absent from gnomAD v2.1.1 and v4.1 (PM2_supporting). A REVEL score of 0.924 meets PP3_supporting (>0.75). This variant resides within the conserved catalytic kinase domain but does not affect a known critical residue (PM1_moderate). The variant has been reported in four unrelated PAH probands (PMID: 15146475, 16429395, 21737554) with additional citations referring back to the same individuals (PMID: 21801371, 32634488, 30578397) (PS4_moderate). A different missense variant at the same amino acid residue, p.Cys420Arg (PMID: 11115378, 21801371) was previously classified by the PH VCEP as pathogenic (PM5_moderate). In summary, this variant meets the criteria to be classified as a likely pathogenic variant for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PS4_moderate, PM1_moderate, PM5_moderate, PM2_supporting, PP3_supporting (VCEP specification version 1.1, 1/18/2024). -
Primary pulmonary hypertension Pathogenic:1
This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 420 of the BMPR2 protein (p.Cys420Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with pulmonary arterial hypertension (PMID: 15146475, 21737554, 21801371; Invitae). ClinVar contains an entry for this variant (Variation ID: 425907). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BMPR2 protein function. This variant disrupts the p.Cys420 amino acid residue in BMPR2. Other variant(s) that disrupt this residue have been observed in individuals with BMPR2-related conditions (PMID: 21801371, 27453251), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
Pulmonary hypertension, primary, 1 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at